- Home
- FBRT vs XNCR Comparison
FBRT vs XNCR Comparison
Compare FBRT & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- XNCR
- Stock Information
- Founded
- FBRT 2012
- XNCR 1997
- Country
- FBRT United States
- XNCR United States
- Employees
- FBRT N/A
- XNCR N/A
- Industry
- FBRT Real Estate Investment Trusts
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- FBRT Real Estate
- XNCR Health Care
- Exchange
- FBRT Nasdaq
- XNCR Nasdaq
- Market Cap
- FBRT 882.8M
- XNCR 1.1B
- IPO Year
- FBRT 1985
- XNCR 2013
- Fundamental
- Price
- FBRT $10.83
- XNCR $13.20
- Analyst Decision
- FBRT Strong Buy
- XNCR Buy
- Analyst Count
- FBRT 4
- XNCR 11
- Target Price
- FBRT $14.75
- XNCR $22.20
- AVG Volume (30 Days)
- FBRT 572.5K
- XNCR 1.4M
- Earning Date
- FBRT 10-29-2025
- XNCR 11-06-2025
- Dividend Yield
- FBRT 13.11%
- XNCR N/A
- EPS Growth
- FBRT 18.52
- XNCR N/A
- EPS
- FBRT 0.98
- XNCR N/A
- Revenue
- FBRT $207,768,000.00
- XNCR $146,929,000.00
- Revenue This Year
- FBRT $25.18
- XNCR $23.31
- Revenue Next Year
- FBRT $0.37
- XNCR N/A
- P/E Ratio
- FBRT $11.05
- XNCR N/A
- Revenue Growth
- FBRT 16.05
- XNCR N/A
- 52 Week Low
- FBRT $9.79
- XNCR $6.92
- 52 Week High
- FBRT $13.58
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- FBRT 47.38
- XNCR 56.09
- Support Level
- FBRT $10.52
- XNCR $12.17
- Resistance Level
- FBRT $10.88
- XNCR $15.69
- Average True Range (ATR)
- FBRT 0.15
- XNCR 1.18
- MACD
- FBRT 0.02
- XNCR -0.18
- Stochastic Oscillator
- FBRT 78.92
- XNCR 47.62
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.